New research from the Centre for Heart Lung Innovation (HLI) at St. Paul’s Hospital has identified inflammation in the lungs’ smallest airways as the cause of pulmonary long COVID. A […]
Peripheral Immune-Mediated Neuropathy Before and During the COVID-19 Pandemic: A Retrospective Cross-Sectional Study in a Referral Center
Abstract Background: There are currently seven coronaviruses that can infect humans and the latest addition to these viruses is the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). Infection by SARS-CoV-2 is […]
Long COVID: The Latest on Treatment and Recovery
For many people, a case of COVID-19 lasts a week or two. For millions of adults, though, symptoms stick around for weeks, months, even years. Long COVID is associated with […]
Intranasal Chlorpheniramine for Early Symptomatic Treatment of COVID-19 and the Impact on Long-COVID
Gustavo Ferrer • Fernando Valerio-Pascua • César Alas-Pineda • et.al., DOI: 10.7759/cureus.82736 Abstract This review explores the therapeutic potential of intranasal chlorpheniramine maleate (iCPM) in managing both acute COVID-19 and Long COVID by integrating histamine H1 receptor […]
Ivermectin: A Multifaceted Drug With a Potential Beyond Anti-parasitic Therapy
Baneet Kaur • Cyril Blavo • Mayur S. Parmar, DOI: 10.7759/cureus.56025 Abstract Ivermectin was first discovered in the 1970s by Japanese microbiologist Satoshi Omura and Irish parasitologist William C. Campbell. Ivermectin has become a versatile […]
Effects of Non-invasive Vagus Nerve Stimulation on Inflammatory Markers in COVID-19 Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Amira Mohamed Taha • Amr Elrosasy • Ahmed S. Mohamed •et.al. DOI: 10.7759/cureus.70613 Abstract The international healthcare community has encountered several difficulties because of the COVID-19 pandemic brought on by SARS-CoV-2. COVID-19 can lead to an […]
Inflammatory and Coagulation Marker Changes -Treated COVID-19 Patients
Akinari Tsukada • Daisuke Katagiri • Shinyu Izumi et. al., DOI: 10.7759/cureus.78836 Abstract Introduction Direct hemoperfusion using polymyxin B-immobilized polystyrene fiber column (PMX-DHP) removes endotoxin and inflammatory mediators from the blood. This study aimed to evaluate […]
Post-COVID-19 Inflammatory Arthritis Treated With Upadacitinib: A Case Report
Cherie S. Zhi • Ami Ben-Artzi, DOI: 10.7759/cureus.78799 Abstract Two patients who developed inflammatory arthritis following COVID-19 infection are presented, characterized by arthralgias, arthritis, and elevated markers of inflammation (C-reactive protein). Both patients […]
Biden officials knew about potential COVID-19 vaccine risks — and took steps to downplay them, scathing Senate report
By Ryan King, New York Post Top federal health officials actively took steps to “delay warning the public” for months in 2021 about the potential risks of heart-related complications from receiving […]
Study: Long COVID ‘brain fog’ linked to inflammation, stress markers
Crystal Bonvillian, The Hill A new study indicates the debilitating “brain fog” suffered by millions of long COVID patients is linked to changes in the brain, including inflammation and an impaired ability […]